attachment

Explain

Reading File
Finding Sources
Searching PubMed

gynecomastia etiology pathogenesis hormonal

Reading File
Reading File
Reading File
Loading Image
Finding Sources
I have everything I need for a thorough answer. Here is the complete explanation:

Gynecomastia - Etiology, Hormonal Dependency, and Pathogenesis

Definition

Gynecomastia is enlargement of the male breast gland. True gynecomastia involves glandular breast tissue >4 cm in diameter (often tender, firmer than fat, with fibrous-like cords) and must be distinguished from pseudogynecomastia (simple excess adipose tissue without glandular proliferation).
  • Harrison's Principles of Internal Medicine 22E, p. 3159
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 965

Core Hormonal Mechanism (Pathogenesis)

The fundamental defect is a relative or absolute increase in the estrogen-to-androgen ratio at the level of breast tissue.
  • Estrogens stimulate ductal epithelial proliferation and connective tissue growth in the breast
  • Androgens counteract this effect
  • When this balance is disrupted - either by too much estrogen, too little androgen, or impaired androgen action - breast glandular tissue proliferates
Histologically, there is:
  • Increase in dense collagenous connective tissue
  • Epithelial hyperplasia of the duct lining
  • Lobule formation is almost never seen (important distinction from female breast)

Etiology - Classification of Causes

1. Physiologic Gynecomastia (Normal at 3 Life Stages)

StageMechanism
NeonatalTransplacental transfer of maternal and placental estrogens
PubertalHigh estrogen-to-androgen ratio in early puberty (transient)
Aging/SenescentIncreased aromatase activity in fat + age-related decline in testosterone

2. Pathologic Causes

A. Androgen Deficiency (Hypogonadism)

Any cause of testosterone deficiency leads to gynecomastia because estrogen synthesis continues via aromatization of residual adrenal and gonadal androgens:
  • Klinefelter syndrome (47,XXY) - a characteristic feature
  • Androgen insensitivity disorders
  • Bilateral orchiectomy, mumps orchitis, testicular torsion
  • Androgen deprivation therapy (GnRH analogues +/- AR blockers) in prostate cancer - causes painful breast enlargement

B. Excess Estrogen Production

  • Leydig cell tumors and Sertoli cell tumors (the latter alone or in Peutz-Jeghers syndrome or Carney complex)
  • Granulosa cell tumors and adrenal tumors producing estrogen precursors
  • hCG-secreting tumors (testicular germ cell tumors) - hCG stimulates Leydig cells to produce excess estrogen

C. Increased Peripheral Aromatization (Androgen → Estrogen Conversion)

  • Obesity - adipose tissue is rich in aromatase; increased conversion of androstenedione to estrone
  • Liver disease (cirrhosis) - diminished catabolism of androstenedione shunts precursors toward peripheral aromatase; the liver normally metabolizes estrogens
  • Hyperthyroidism - elevates SHBG, which increases the free estradiol-to-free testosterone ratio
  • Congenital adrenal hyperplasia (CAH) - increased substrate availability (androstenedione)
  • Familial aromatase excess syndrome - autosomal dominant or X-linked disorder; chimeric CYP19 gene activated by regulatory elements of neighboring genes (TRPM7, TMOD3), causing excessive estrogen production in fat and extragonadal tissues; presents with peripubertal gynecomastia, advanced bone age, short stature, premature epiphyseal closure, and hypogonadotropic hypogonadism

D. Drug-Induced Gynecomastia

Drugs act through multiple mechanisms:
MechanismExamples
Direct estrogen-like actionOral contraceptives, phytoestrogens, digitalis
Inhibit androgen synthesisGnRH agonists, ketoconazole
Block androgen receptorSpironolactone, enzalutamide, flutamide
Mechanism unclearCimetidine, imatinib, antiretrovirals (ART for HIV), alcohol, marijuana, heroin, anabolic steroids
Note: Spironolactone binds androgen receptors as an antagonist and is a classic cause of drug-induced gynecomastia.

Summary Diagram - Diagnostic Evaluation

Evaluation of gynecomastia flowchart (Harrison's 22E, Fig. 403-7)
The flowchart guides workup based on tissue type and hormonal findings:
  • Low T + high E2/T ratio → testosterone deficiency workup
  • High E2 + normal/low T → search for estrogen-secreting tumor (testicular/adrenal ultrasound)
  • Elevated hCGβ → search for hCG-producing tumor
  • Very high SHBG → measure free T and E2, find cause of elevated SHBG

Quick Memory Aid

GYNECOMASTIA = Estrogen UP or Androgen DOWN
CategoryKey Examples
PhysiologicNeonatal, Pubertal, Aging
HypogonadismKlinefelter, orchiectomy, GnRH therapy
Tumor-relatedLeydig cell tumor, Sertoli cell tumor, hCG-secreting GCT
Liver diseaseCirrhosis (key cause)
ObesityIncreased aromatase in fat
HyperthyroidismElevated SHBG
DrugsSpironolactone, cimetidine, ketoconazole, antiretrovirals, anabolic steroids
FamilialCYP19/aromatase excess syndrome

Sources: Harrison's Principles of Internal Medicine 22E (p. 3159-3160) | Robbins & Cotran Pathologic Basis of Disease | Henry's Clinical Diagnosis (Laboratory Methods)
This is a shared conversation. Sign in to Orris to start your own chat.